CME Group reported Q1 2026 adjusted EPS of $3.36, topping consensus $3.31 by $0.05.
Revenue reached a record $1.9 billion, up 14% YoY and beating the $1.85 billion estimate.
Average daily volume hit 36.2 million contracts, a 22% YoY rise with records across all six asset classes.
Despite strong results, shares slipped 1.5% pre‑market; CME paid $2.7 billion dividends and repurchased $536 million of stock.